Product Images Asenapine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 16 images provide visual information about the product associated with Asenapine NDC 51991-928 by Breckenridge Pharmaceutical, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - asenapine 01

Chemical Structure - asenapine 01

Figure 1 - asenapine 02

Figure 1 - asenapine 02

This text appears to be a table listing different drugs and their effects on the metabolic enzymes in the body. It includes information on which drugs inhibit or induce certain enzymes and their impact on pharmacokinetic parameters such as Cmax and AUC. Additionally, there is an example given of the effect of the CYP1A2 inhibitor fluvoxamine on asenapine exposure. Overall, this table could be useful for clinicians in understanding potential drug interactions and their effects on medication metabolism.*

Figure 2 - asenapine 03

Figure 2 - asenapine 03

Figure 3 - asenapine 04

Figure 3 - asenapine 04

This text provides information on population description based on Renal and Hepatic impairment, smoker, Japanese ethnicity, and Pediatries. The data includes information on PK, Cmax, AUC, and fold change with 90% CI. The reference population for renal and hepatic impairment is individuals with normal renal and hepatic function, respectively. Furthermore, the data for smokers is relative to non-smokers, whereas the data for Japanese is relative to Caucasians, and the data for pediatrics is relative to adults.*

Figure 4 - asenapine 05

Figure 4 - asenapine 05

Figure 5 - asenapine 06

Figure 5 - asenapine 06

The text describes a graph comparing the efficacy of Asenapine sublingual tablets versus placebo, represented by the number of days to relapse. The graph shows that Asenapine resulted in a longer time to relapse than placebo. The estimators used in the graph are based on the Kaplan-Meier distribution with censoring.*

Figure A - asenapine 07

Figure A - asenapine 07

Figure B - asenapine 08

Figure B - asenapine 08

Figure C - asenapine 09

Figure C - asenapine 09

Figure D - asenapine 10

Figure D - asenapine 10

Figure E - asenapine 11

Figure E - asenapine 11

PRINCIPAL DISPLAY PANEL - 10 mg Tablet Blister Pack Box - 51991-360 - asenapine 12

PRINCIPAL DISPLAY PANEL - 10 mg Tablet Blister Pack Box - 51991-360 - asenapine 12

Asenapine sublingual tablets are available in a pack containing 60 unit-dose sublingual tablets. Each sublingual tablet contains asenapine (5mg as maleate), aspartame, colloidal silicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, and peppermint flavor. This medication should be used only by placing the tablet under the tongue. The pack must be stored at 20° to 25° C (66° to 77° F). It is manufactured and distributed by Torga Pharmaceuticals. It is important to keep the medication out of the reach of children. This medicine may contain Phenylalanine in the amount of 0.17 mg per tablet.*

PRINCIPAL DISPLAY PANEL - 2.5 mg Tablet Blister Pack Box - asenapine 13

PRINCIPAL DISPLAY PANEL - 2.5 mg Tablet Blister Pack Box - asenapine 13

The text is a product description for Asenapine Sublingual Tablets with the warning to keep the medication out of reach of children. Each sublingual tablet contains 10mg of Asenapine and has Phenylalanine, Magnesium, and Povidone as ingredients. Dosage information is not available. The tablets are for sublingual use only and should not be chewed or swallowed. The recommended storage temperature is 20°C to 25°C. The manufacturer's information is provided, and the packaging contains 60 unit-dose tablets.*

PRINCIPAL DISPLAY PANEL - 10 mg Tablet Blister Pack Box - 51991-361 - asenapine 14

PRINCIPAL DISPLAY PANEL - 10 mg Tablet Blister Pack Box - 51991-361 - asenapine 14

This is a description of Asenapine Sublingual Tablets. Each tablet contains 5mg of asenapine as well as other ingredients. The tablets have a black cherry flavor, and they are intended for sublingual (under the tongue) use only. The package contains 60 unit-dose tablets. There are instructions on the other side of the package. The medication should be stored at a temperature between 68-77 degrees Fahrenheit. The package warns to keep the medication away from children.*

asenapine 15

asenapine 15

The text contains information about Asenapine sublingual tablets with black cherry flavor. The tablets come in unit-dose of 60 tablets and each tablet contains 10mg of Asenapine, magnesium stearate, povidons, aspartame, and black cherry flavor among other components. The dosage is not provided and the user should refer to the package insert for instructions. The storage temperature is 20-25°C, and the medication should be kept out of reach of children. The text also contains manufacturer and distributor information and cautions against using the medication through other routes of administration.*

asenapine 16

asenapine 16

This is a description of a medication called Asenapine Sublingual Tablets. The medication comes in a 60 unit-dose tablet pack with a recommended storage temperature of 20°C to 25°C. The tablets contain 25mg of asenapine and are intended for sublingual use. In addition to asenapine, the tablets consist of several components including phenylalanine and aspartame. The medication is flavored with black cherry flavor and should not be cut, chewed, or swallowed. The usage instructions and additional details can be found on the back of the package.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.